Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: A case report and review of literature

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 445-448

  Hsieh, Pei Chun ^a   Chen, Shu Min ^a,b,c   Guo, Yao Hong ^a   Kuan, Ta Shen ^a,b   Yen, Wei Jang ^a   Chang, Wen Chen ^a   Lin, Yu Ching ^a,b,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Acetazolamide; Dystonia; Movement disorders; Multiple sclerosis; Rehabilitation

Indexed keywords

ACETAZOLAMIDE; BACLOFEN; IMIPRAMINE; INTERFERON BETA SERINE; METHYLPREDNISOLONE;

ADULT; ARTICLE; ATAXIA; BLURRED VISION; BRAIN STEM; CASE REPORT; CEREBELLUM; CERVICAL SPINAL CORD; CORPUS CALLOSUM; DRUG MEGADOSE; DYSPHAGIA; FEMALE; FOLLOW UP; HEMIPARESIS; HUMAN; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN; OCCUPATIONAL THERAPY; OPTIC NEURITIS; PARESTHESIA; PAROXYSMAL DYSTONIA; SLURRED SPEECH; SPASTICITY; THORACIC SPINAL CORD;

EID: 84876008684     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S43688     Document Type: Article

References (19)

1. Shneyder N, Harris MK, Minagar A. Movement disorders in patients with multiple sclerosis. Handb Clin Neurol. 2011;100:307-314.
2. Thompson AJ, Toosy AT, Ciccarelli O. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol. 2010;9(12):1182-1199.
3. Dressler D, Benecke R. Diagnosis and management of acute movement disorders. J Neurol. 2005;252(11):1299-1306.
4. Usmani N, Bedi G, Lam BL, Sheremata WA. Association between paroxysmal tonic spasms and neuromyelitis optica. Arch Neurol. 2012;69(1):121-124.
5. Trompetto C, Avanzino L, Bove M, Buccolieri A, Uccelli A, Abbruzzese G. Investigation of paroxysmal dystonia in a patient with multiple sclerosis: a transcranial magnetic stimulation study. Clin Neurophysiol. 2008;119(1):63-70.
6. Delgado S, Baez S, Singer C, Sengun C, Sheremata WA, Papapetropoulos S. Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies. Mov Disord. 2009;24(2):309-311.
7. Schmidt FR, Costa FH, Silva FM, et al. Paroxysmal dystonia and neuromyelitis optica. Arq Neuropsiquiatr. 2012;70(4):271-272.
8. Aguirregomozcorta M, Ramió-Torrentà L, Gich J, Quiles A, Genís D. Paroxysmal dystonia and pathological laughter as a first manifestation of multiple sclerosis. Mult Scler. 2008;14(2):262-265.
9. Sethi KD, Hess DC, Huffnagle VH, Adams RJ. Acetazolamide treatment of paroxysmal dystonia in central demyelinating disease. Neurology. 1992;42(4):919-921.
10. Nardocci N, Zorzi G, Savoldelli M, Rumi V, Angelini L. Paroxysmal dystonia and paroxysmal tremor in a young patient with multiple sclerosis. Ital J Neurol Sci. 1995;16(5):315-319.
11. Waubant E, Alizé P, Tourbah A, Agid Y. Paroxysmal dystonia (tonic spasm) in multiple sclerosis. Neurology. 2001;57(12):2320-2321.
12. Berger JR, Sheremata WA, Melamed E. Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Arch Neurol. 1984;41(7): 747-750.
13. Minagar A, Sheremata WA, Weiner WJ. Transient movement disorders and multiple sclerosis. Parkinsonism Relat Disord. 2002;9(2): 111-113.
14. Deutsch SI, Rosse RB, Connor JM, Burket JA, Murphy ME, Fox FJ. Current status of cannabis treatment of multiple sclerosis with an illustrative case presentation of a patient with MS, complex vocal tics, paroxysmal dystonia, and marijuana dependence treated with dronabinol. CNS Spectr. 2008;13(5):393-403.
15. Rüegg SJ, Bühlmann M, Renaud S, Steck AJ, Kappos L, Fuhr P. Cervical dystonia as first manifestation of multiple sclerosis. J Neurol. 2004;251(11):1408-1410.
16. Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics. 2007;4(2):267-273.
17. Michel V, Riant F, Tournier-Lasserve E, et al. Long-term improvement of paroxysmal dystonic choreathetosis with acetazolamide. J Neurol. 2006;253(10):1362-1364.
18. Olson WL Jr. Acetazolamide relieves concurrent episodic movement disorders encountered in Southern states. South Med J. 1999;92(2): 228-232.
19. Richter A, Hamann M. The carbonic anhydrase inhibitor acetazolamide exerts antidystonic effects in the dt(sz) mutant hamster. Eur J Pharmacol. 2004;502(1-2):105-108.